1. Home
  2. LND vs IFRX Comparison

LND vs IFRX Comparison

Compare LND & IFRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

LND

Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

N/A

Current Price

$3.84

Market Cap

373.6M

ML Signal

N/A

Logo InflaRx N.V.

IFRX

InflaRx N.V.

N/A

Current Price

$2.30

Market Cap

303.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LND
IFRX
Founded
2005
2007
Country
Brazil
Germany
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
373.6M
303.4M
IPO Year
2010
2017

Fundamental Metrics

Financial Performance
Metric
LND
IFRX
Price
$3.84
$2.30
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$6.25
AVG Volume (30 Days)
51.9K
976.3K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
3.18%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.65
N/A
Revenue Next Year
$6.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.46
$0.80
52 Week High
$4.45
$2.95

Technical Indicators

Market Signals
Indicator
LND
IFRX
Relative Strength Index (RSI) 63.02 60.09
Support Level $3.70 $2.25
Resistance Level $3.88 $2.57
Average True Range (ATR) 0.09 0.16
MACD 0.02 0.01
Stochastic Oscillator 91.43 59.60

Price Performance

Historical Comparison
LND
IFRX

About LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.

About IFRX InflaRx N.V.

InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

Share on Social Networks: